Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $75.42m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Portfolio Update - Update on MBC finalisation

28 Mar 2025 11:45

RNS Number : 7291C
Life Settlement Assets PLC
28 March 2025
 

This announcement contains inside information

 

Life Settlement Assets PLC (the "Company" or "LSA")

LEI: 2138003OL2VBXWG1BZ27

Update on MBC finalisation

The Company provides an update on the finalisation of the absorption of the MBC portfolio in the Company's asset base.

LSA, the closed end investment trust which manages portfolios of whole interests in life settlement policies issued by life insurance companies, has made steady progress during 2024 on the finalisation of administrative arrangements relating to the MBC action. During 2024 the Company reported that on 28 August 2024 it received notification that funds amounting to USD 9.7 million had been received by the Company, comprising the first tranche of the MBC sale proceeds of USD 5.7 million and the return of overpaid premiums of USD 4.0 million. The impact of this refund was reflected in the 31 July 2024 Net Asset Value of USD 2.33 per share released to the market on 16 September 2024.

The second and final tranche of the MBC sale proceeds of up to USD 6.0 million is expected to be received by the Company during 2025 and has previously been included in the Company's NAV.

However, since the year end further examination of the portfolio acquired from the MBC Trustee by LSA's Investment Manager has revealed that the MBC Trustee had previously not exercised an extension to a particular policy which extended the maturity from 100 to 120 years. This is likely to have a detrimental impact on the NAV of USD 3-4%. A further announcement regarding this will be made in due course.

Michael Baines, Chairman of LSA, said, "This news relating to a previous decision taken by the MBC Trustee is disappointing, and it underlines the correctness of our strategy to take full control of all our policies, removing the dependence on external third parties to maintain the value in our policies. Despite the decision taken by the MBC Trustee, the results of the acquisition have been very favourable for the Company."

 

For further information, please contact:

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Gillian Martin / Anita Ghanekar / Harry Davies-Ball

020 7408 4090

 

ISCA Administration Services Limited (the Company Secretary) on

01392 487056; or lsa@iscaadmin.co.uk

 

28 March 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUJPMBTMTJTBFA
Date   Source Headline
8th Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202510:09 amRNSTotal Voting Rights
28th Mar 202511:45 amRNSPortfolio Update - Update on MBC finalisation
18th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20252:01 pmRNSNet Asset Value(s)
3rd Mar 202510:03 amRNSTotal Voting Rights
5th Feb 20254:58 pmRNSTransaction in Own Shares
3rd Feb 20258:51 amRNSTotal Voting Rights
16th Jan 202510:33 amRNSNet Asset Value(s)
6th Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTotal Voting Rights
27th Dec 20247:00 amRNSTransaction in Own Shares
18th Dec 20245:10 pmRNSTransaction in Own Shares
16th Dec 20247:00 amRNSTransaction in Own Shares
13th Dec 20247:00 amRNSNet Asset Value(s)
3rd Dec 20247:00 amRNSTransaction in Own Shares
2nd Dec 20249:24 amRNSDirector Declaration
22nd Nov 20242:05 pmRNSNet Asset Value(s)
1st Nov 20247:30 amRNSTotal Voting Rights
1st Nov 20247:01 amRNSTransaction in Own Shares
23rd Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:42 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20249:41 amRNSTotal Voting Rights
20th Sep 20245:27 pmRNSTransaction in Own Shares
20th Sep 20247:00 amRNSHalf-year Report
16th Sep 20247:00 amRNSNet Asset Value(s)
29th Aug 20247:00 amRNSStatement re Update on MBC settlement
12th Aug 20245:16 pmRNSHolding(s) in Company
2nd Aug 20241:15 pmRNSNet Asset Value(s)
1st Aug 20248:09 amRNSTotal Voting Rights
30th Jul 20246:17 pmRNSHolding(s) in Company
29th Jul 20244:51 pmRNSHolding(s) in Company
25th Jul 20247:00 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
16th Jul 20248:15 amRNSTransaction in Own Shares
15th Jul 20247:00 amRNSTransaction in Own Shares
12th Jul 20247:00 amRNSTransaction in Own Shares
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 20247:00 amRNSNet Asset Value(s)
1st Jul 202410:33 amRNSTotal Voting Rights
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:57 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20242:49 pmRNSAGM Statement
13th Jun 20241:13 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.